user

Ovarian cancer ex vivo 3D tumor cultures predict patient specific drug sensitivity

被引：0
|
作者：
Grillet, Fanny [1 ]
Jariani, Abbas [1 ]
Overkamp, Juul [2 ]
Daszkiewicz, Lidia [2 ]
Yan, Kuan [2 ]
Price, Leo S. [2 ]
Vader, Willemijn [1 ]
机构：
[1] VitroScan BV, Leiden, Netherlands
[2] OCellO BV, Leiden, Netherlands
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4159
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4159
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Patient specific drug sensitivity to novel treatment approaches in ovarian cancer ex vivo 3D tumor cultures
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo
    Vader, Willemijn
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [2] Predicting drug sensitivity in patient derived ex vivo 3D mesothelioma cultures
    Cornelissen, Robin
    Dumouline, Daphne
    Thusen, Janvd
    Basten, Sander
    Grillet, Fanny
    Yan, Kuan
    Price, Leo
    Vader, Willemijn
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Predicting PARPi sensitivity in patient derived ex vivo 3D tumor cultures
    Basten, Sander
    Herpers, Bram
    Yan, Kuan
    Vader, Willemijn
    Price, Leo
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Predicting PARPi sensitivity in patient derived ex vivo 3D tumour cultures
    Basten, S.
    Overkamp, J.
    Herpers, B.
    Yan, K.
    Price, L.
    Vader, W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 103 : E104 - E104
  • [5] Chemotherapy sensitivity score based on ex vivo 3D tumour testing to predict clinical response for ovarian cancer patients
    Walraven, J.
    de Kroon, C. D.
    van Altena, A.
    van der Meer, D.
    Ceton, L.
    van der Valk, J.
    Sijsenaar, T.
    Grillet, F.
    Montero, M. Garcia
    Vader, W.
    Ottevanger, P. B.
    Kroep, J. R.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S527 - S527
  • [6] Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
    Akerlund, Emma
    Gudoityte, Greta
    Lamodiere, Elisabeth Moussaud
    Carlson, Joseph
    Wallin, Emelie
    Fernebro, Josefin
    Kallioniemi, Olli
    Ostling, Paivi
    Joneborg, Ulrika
    Seashore-Ludlow, Brinton
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [7] Protocol for quantifying drug sensitivity in 3D patient- derived ovarian cancer models
    Labrosse, Kathrin B.
    Lombardo, Flavio C.
    Rimmer, Natalie
    Lopez, Monica Nunez
    Fedier, Andre
    Heinzelmann-Schwarz, Viola
    Coelho, Ricardo
    Jacob, Francis
    [J]. STAR PROTOCOLS, 2024, 5 (03):
  • [8] 3D EX VIVO PATIENT TISSUE PLATFORM FOR IMMUNOONCOLOGY DRUG TESTING
    Basten, Sander
    Beztsinna, Nataliia
    Grillet, Fanny
    Yan, Kuan
    Meesters, Niels
    van der Meer, Donny
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A212 - A212
  • [9] Classification of patient-specific sensitivity to immunotherapies by ex vivo tumor testing
    Ceton, Lieke Johanna
    Montero, Marta Garcia
    Grillet, Fanny
    van der Meer, Dieudonne J.
    Vader, Willemijn
    van Altena, Anne
    de Kroon, Cor D.
    Ottevanger, Nelleke
    Kroep, Judith
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [10] Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing
    Lohse, Ines
    Azzam, Diana J.
    Al-Ali, Hassan
    Volmar, Claude-Henry
    Brothers, Shaun P.
    Ince, Tan A.
    Wahlestedt, Claes
    [J]. ANTICANCER RESEARCH, 2019, 39 (08) : 4023 - 4030
12345